What is MicroSynbiotiX?
MicroSynbiotiX is an emerging biotechnology firm headquartered in Cork City, Ireland, focused on revolutionizing aquaculture by reducing antibiotic use. Leveraging advanced algal genomics and molecular biology, the company engineers microalgae to produce therapeutic proteins and vaccines. This novel oral delivery system aims to significantly lower production costs, making effective treatments more accessible. The technology addresses critical issues in fish farming, including disease prevention, reduced mortality, and the broader goal of enhancing global food security by mitigating the impact of bacterial and viral outbreaks on fish stocks.
How much funding has MicroSynbiotiX raised?
MicroSynbiotiX has raised a total of $1.2M across 1 funding round:
Angel/Seed
$1.2M
Angel/Seed (2017): $1.2M, investors not publicly disclosed
What's next for MicroSynbiotiX?
With its recent strategic investment, MicroSynbiotiX is poised for accelerated growth and the scaling of its innovative solutions. The company's focus on developing cost-effective, user-friendly vaccines and therapeutics for aquaculture positions it to capture a substantial market share. Future developments will likely involve expanding production capabilities, further clinical validation of its microalgae-based delivery system, and forging strategic partnerships to broaden its global reach. This capital infusion is expected to fuel research and development, enabling MicroSynbiotiX to further its mission of creating a more sustainable and secure global food supply chain.
See full MicroSynbiotiX company page
